Life Science News & Medical Media Coverage

Endocrinology4 Aug 2026

Weekly growth hormone therapy: a safer path to long-term height gains?Read article

Pediatrics26 Jul 2026

The Benadryl Challenge: Why public health officials are struggling to stop this deadly trend Read article

Dermatology11 Aug 2026

Creatine supplementation in hemodialysis: A futile exercise?Read article

Healthcare Sys & Biz28 Jul 2026

NHS waiting lists shorten, but regional disparities persist for patients Read article

Nephrology28 Jul 2026

IgA nephritis in older transplant patients: a data desert for optimal care Read article

Cardiology10 Aug 2026

Safe caffeine intake does not harm heart health Read article

Neurology4 Aug 2026

Beyond screen time: How short videos rewire dopamine pathways Read article

1050+Articles published

29Therapy areas

WeeklyClinical newsletter

FreeAlways

Special Reports from The Life Science Feed. This is sketchy. Our reports are not.

HighlightsView all →

Cardiology

Safe caffeine intake does not harm heart health

Established guidelines for safe caffeine intake do not pose a risk to cardiovascular health, despite the expanding market of caffeine-containing products.

Gastroenterology

Cannabinoid hyperemesis: Why cannabis users self-medicate with hot showers

Cannabinoid hyperemesis syndrome presents as cyclic vomiting in chronic cannabis users, a diagnosis often delayed due to its mimicry of other conditions.

Endocrinology

Setmelanotide curbs insatiable hunger in acquired hypothalamic obesity

Setmelanotide significantly improved body mass index, hunger, and hyperphagia symptoms in patients with acquired hypothalamic obesity, according to the TRANSCEND trial.

Neurology

Biomarkers hint at who recovers motor function after stroke

An exploratory substudy of the PRACTISE trial identified specific biomarkers linked to upper-extremity motor recovery after stroke, including neuroplasticity and inflammatory markers.

Dermatology

Lebrikizumab maintains atopic dermatitis remission for months off-therapy

Lebrikizumab monotherapy sustained deep remission in atopic dermatitis patients for up to 38 weeks after treatment cessation.

Healthcare Sys & Biz

Prior Authorization: Why 'Fighting Back' Is Now Standard Practice

Navigating prior authorization is a significant burden for clinicians, often requiring multiple appeals to secure necessary patient care.

Haematology

The Neutropenic Diet: An Unnecessary Burden for Leukemia and Transplant Patients?

A liberalized diet was noninferior to the traditional neutropenic diet for preventing major infections in patients with acute leukemia or undergoing stem-cell transplant.

Oncology

Emotional support after cancer: What works for young adults?

Educational guidance sessions and video-based group music therapy show promise in addressing the emotional strain and identity shifts faced by young cancer patients.

OncologyView all →

Prostatic Neoplasms

Pluvicto's expanded approval: What it means for advanced prostate cancer

The FDA expanded Pluvicto's approval for PSMA-positive metastatic castration-resistant prostate cancer, making it available earlier in the treatment sequence.

Solid Tumors

Emotional support after cancer: What works for young adults?

Educational guidance sessions and video-based group music therapy show promise in addressing the emotional strain and identity shifts faced by young cancer patients.

Oncology

Alternative cancer clinics: More harm than hope for your patients

Unconventional cancer clinics offer unproven therapies, often preying on patient desperation. These treatments lack scientific validation and can pose significant risks.

Solid Tumors

Why do some tissues resist oncogenesis, even with mutations?

What The Life Science Feed is